Results
1 -
10 of
18Bagal Sharan K., Brown Alan D., Cox Peter J., Omoto Kiyoyuki, Owen Robert M., Pryde David C., Sidders Benjamin, Skerratt Sarah E., Stevens Edward B., Storer R. Ian, Swain Nigel A..
Ion Channels as Therapeutic Targets: A Drug Discovery Perspective, Journal of Medicinal Chemistry, 2013 Susceptibility to Soman Toxicity and Efficacy of LY293558 Against Soman-Induced Seizures and Neuropathology in 10-Month-Old Male Rats, Neurotoxicity Research Glutamate Receptor Ligands, Analgesia Effects of Glutamate Receptor Antagonists on Lower Urinary Tract Function in Conscious Unanesthetized Rats, Advances in Bladder Research Morphine Withdrawal as a State of Glutamate Hyperactivity, Glutamate and Addiction Selective protection against AMPA- and kainate-evoked neurotoxicity by (3S,4aR,6R,8aR)-6-[2-(1(2)H-tetrazole-5-yl)ethyl]decahydroisoquinoline-3-carboxylic acid (LY293558) and its racemate (LY215490), Journal of Neural Transmission Locomotor activity detects subunit-selective effects of agonists and decahydroisoquinoline antagonists at AMPA/kainic acid ionotropic glutamate receptors in adult rats, Psychopharmacology Examining the neural targets of the AMPA receptor potentiator LY404187 in the rat brain using pharmacological magnetic resonance imaging, Psychopharmacology In vitro and in vivo studies in rats with LY293558 suggest AMPA/kainate receptor blockade as a novel potential mechanism for the therapeutic treatment of anxiety disorders, Psychopharmacology Seeking the best care for acute migraine, The Journal of Headache and Pain